Published in Medical Letter on the CDC and FDA, November 26th, 2006
OPC is a fungal infection of the mouth and throat caused by the yeast Candida. Noxafil is a triazole antifungal agent discovered and developed by Schering-Plough Research Institute.
This approval follows FDA approval of Noxafil for prophylaxis (prevention) of invasive Aspergillus and Candida infections in patients 13 years of age and older who are at high risk of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.